title: Subsequent Neoplasms in Adult Survivors of Childhood Genitourinary Tumors.
abstract: Treatment for childhood genitourinary tumors such as Wilms tumor, rhabdomyosarcoma, and germ cell tumors has progressed to the point that cure can be expected in many cases. However, survivorship is often coupled with a variety of late effects, of which subsequent neoplasms may be the most concerning if not the most life threatening. Here, we review current literature to assess and report issues relating to subsequent neoplasms in patients with a history of childhood genitourinary tumors, including causative factors, overall risks, the most prevalent subsequent neoplasms, and current recommendations for surveillance and screening.
authors.affiliation: Division of Pediatric Urology, Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN; Division of Pediatric Urology, Department of Urology, University of Tennessee Health Science Center, Memphis, TN.
authors.forename: Derrick L
authors.initials: DL
authors.lastname: Johnston
authors.affiliation: Solid Tumor Division, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN.
authors.forename: Michael W
authors.initials: MW
authors.lastname: Bishop
authors.affiliation: Division of Cancer Survivorship, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN.
authors.forename: Melissa M
authors.initials: MM
authors.lastname: Hudson
authors.affiliation: Division of Pediatric Urology, Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN; Division of Pediatric Urology, Department of Urology, University of Tennessee Health Science Center, Memphis, TN. Electronic address: danagiel@gmail.com.
authors.forename: Dana W
authors.initials: DW
authors.lastname: Giel
mesh_terms: D000328:Adult; D003131:Combined Modality Therapy; D019468:Disease Management; D005544:Forecasting; D014943:Global Health; D006801:Humans; D008297:Male; D009017:Morbidity / Q000639:trends; D015996:Survival Rate / Q000639:trends; D017741:Survivors; D014565:Urogenital Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy